EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Early Recurrence of HCC Is Driven by Inflammation-Related HIF-1α Independent Angiogenesis Rather than Hypoxia-Induced Immune Escape

Lianda Siregar, Rino Alvani Gani, Toar J M Lalisang, Irsan Hasan, Suhendro, Heriawan Soejono, Siti Boedina Kresno, Nurjati Chairani Siregar, Muhammad Begawan Bestari

Biomolecules · 14.05.2026 · 16 (5) · 723

DOI: 10.3390/biom16050723 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Biomolecules, online erschienen am 14.05.2026. Verfasst von Lianda Siregar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta 10430, Indonesia. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Indonesia, Dharmais National Cancer Hospital, Universitas Indonesia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) shows a high rate of early recurrence after curative resection, indicating a critical contribution of tumor microenvironment-driven molecular mechanisms. Early recurrence of hepatocellular carcinoma is defined as recurrence within 6 months after curative resection, with a prevalence exceeding 30%. Hypoxia signaling and immune dysregulation have been implicated, yet their compartment-specific relevance remains unclear.

Methods

This multicenter nested case–control study included 49 HCC patients to evaluate associations between hypoxia-inducible factor-1 alpha (HIF-1α), vascular endothelial growth factor (VEGF), tumor-infiltrating lymphocytes (TILs), CD4+ T cells, CD8+ T cells, regulatory T cells (Tregs), programmed cell death protein 1 (PD-1), and programmed death-ligand 1 (PD-L1) and early recurrence after resection. TIL density was assessed using hematoxylin and eosin staining, while immunohistochemistry was performed to quantify intratumoral and peritumoral expression of the studied markers. Receiver operating characteristic (ROC) curve analysis was used to evaluate the predictive performance. Recurrence-free survival (RFS) was analyzed using the Kaplan–Meier, and independent predictors were identified using multivariate Cox proportional hazards regression.

Results

Early recurrence occurred in 11 of 49 patients (22.4%) of Child–Pugh A patients. Recurrent tumors were characterized by elevated VEGF expression despite absent HIF-1α, alongside significant depletion of intratumoral TILs (HR 5.02; 95% CI 1.09–23.26), CD4+ (HR 7.68; 95% CI 1.66–35.60) and CD8+ cells (HR 6.68; 95% CI 1.77–25.23) and reduced peritumoral CD8+ infiltration (HR 4.20; 95% CI 1.11–15.91). Multivariable analysis identified low intratumoral CD4+ (HR 7.98; 95% CI 1.63–39.07) and reduced peritumoral CD8+ expression (HR 4.98; 95% CI 1.14–21.70) as independent predictors, whereas HIF-1α, VEGF, Treg, PD-1, and PD-L1 were not significantly associated.

Conclusions

Early HCC recurrence shows HIF-1α-independent angiogenesis alongside spatial immune depletion, supporting integrated immune profiling over single angiogenic markers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Inducible Factor 1, alpha SubunitCarcinoma, HepatocellularLiver NeoplasmsNeoplasm Recurrence, LocalNeovascularization, PathologicInflammationHumansFemaleMaleMiddle AgedCase-Control StudiesVascular Endothelial Growth Factor ATumor MicroenvironmentLymphocytes, Tumor-InfiltratingCD8-Positive T-LymphocytesTumor EscapeAged

Stichwörter der Autor:innen

CD4CD8PD-1PDL1T regulationVEGFangiogenesisearly recurrencehepatocellular carcinomahypoxia

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitHIF1A protein, humanVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta 10430, Indonesia.
  • Department of Digestive Surgery, Faculty of Medicine, Universitas Indonesia, Jakarta 10430, Indonesia.
  • Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia, Jakarta 10430, Indonesia.
  • Department of Pathological Anatomy, Faculty of Medicine, Universitas Indonesia, Jakarta 10430, Indonesia.
  • Department of Internal Medicine, Faculty of Medicine, Universitas Padjajaran, Bandung 40161, Indonesia.

Förderung

  • University of Indonesia
  • Dharmais National Cancer Hospital
  • Universitas Indonesia

Zitieren

APA

Siregar, L., Gani, R. A., Lalisang, T. J. M., Hasan, I., Suhendro, Soejono, H., Kresno, S. B., Siregar, N. C., & Bestari, M. B. (2026). Early Recurrence of HCC Is Driven by Inflammation-Related HIF-1α Independent Angiogenesis Rather than Hypoxia-Induced Immune Escape. Biomolecules, 16(5), 723. https://doi.org/10.3390/biom16050723

Vancouver

Siregar L, Gani RA, Lalisang TJM, Hasan I, Suhendro, Soejono H, et al. Early Recurrence of HCC Is Driven by Inflammation-Related HIF-1α Independent Angiogenesis Rather than Hypoxia-Induced Immune Escape. Biomolecules. 2026;16(5):723. doi:10.3390/biom16050723

BibTeX
@article{Siregar2026,
  author = {Siregar, Lianda and Gani, Rino Alvani and Lalisang, Toar J M and Hasan, Irsan and Suhendro and Soejono, Heriawan and Kresno, Siti Boedina and Siregar, Nurjati Chairani and Bestari, Muhammad Begawan},
  title = {Early Recurrence of HCC Is Driven by Inflammation-Related HIF-1α Independent Angiogenesis Rather than Hypoxia-Induced Immune Escape},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {5},
  pages = {723},
  doi = {10.3390/biom16050723}
}
Kostenlos starten →